HRNR and neoplasm: Interestingly, we did observe a two-fold increase relative to control in cleaved caspase 3 levels in tumors that had been treated with Hrnr siRNA or AV-951 alone, suggesting that enhanced apoptosis in the tumor may be responsible for the decreased tumor burden we observed in these two groups (Supplementary Fig. 10c, d).